Related Experiment Video
Updated: Nov 23, 2025
09:06
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
Published on: October 7, 2025
175
Artificial miRNAs as therapeutic tools: Challenges and opportunities
Anna Kotowska-Zimmer1, Marianna Pewinska1, Marta Olejniczak1
1Department of Genome Engineering, Institute of Bioorganic Chemistry PAS, Poznan, Poland.
Wiley Interdisciplinary Reviews. RNA
|January 2, 2021
Summary
Artificial miRNAs (amiRNAs) offer a safer and more effective RNA interference (RNAi) approach for gene silencing. Their complex structure ensures stable gene inhibition, making them promising for treating diseases like cancer and neurodegenerative disorders.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- RNA interference (RNAi) is a powerful tool for gene function studies and therapeutics.
- Synthetic small interfering RNAs (siRNAs), short hairpin RNAs (shRNAs), and artificial miRNAs (amiRNAs) are key RNAi effectors.
- Artificial miRNAs, also known as miRNA mimics, are complex RNA molecules that undergo two-step processing to yield mature siRNAs.
Purpose of the Study:
- To explore the mechanisms and therapeutic potential of artificial miRNAs (amiRNAs) in gene silencing.
- To highlight the advantages of amiRNAs over other RNAi triggers, focusing on safety and efficacy.
- To discuss the implications of recent research and clinical trials for the advancement of amiRNA-based therapies.
Main Methods:
- Utilizing cellular machinery for the processing of amiRNAs into mature siRNAs.
- Designing amiRNAs with target-specific siRNA inserts and pri-miRNA scaffolds for guided gene silencing.
- Delivering amiRNAs via viral vectors under tissue-specific promoters for sustained gene expression and silencing.
Main Results:
- AmiRNAs mimic endogenous miRNA dynamics, offering enhanced safety compared to other RNAi triggers.
- Vector-based delivery enables long-lasting, tissue-specific gene silencing.
- AmiRNAs demonstrate therapeutic potential for diverse diseases, including neurodegenerative conditions, cancers, and viral infections.
Conclusions:
- Artificial miRNAs represent a sophisticated and safer RNAi technology for therapeutic applications.
- Ongoing research into pri-miRNA processing and clinical trial outcomes will further refine amiRNA utility.
- AmiRNAs hold significant promise for treating a wide range of human diseases, potentially revolutionizing therapeutic strategies.
More Related Videos
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
679
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
679
01:22MicroRNAs
3.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
01:22MicroRNAs
23.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K
02:30siRNA - Small Interfering RNAs
17.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.7K
02:15Experimental RNAi
6.9K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.9K
01:59CRISPR
55.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
55.2K